Based on these findings, the final set of six gene biomarkers (VWF, IL1RL1, DENND2B, MMP14, NAAA, and PANK1) will be used to build and evaluate the best-supervised classification model to distinguish IBD patients from healthy controls. This evidence concerns the gene IL1RL1 and inflammatory bowel disease.